Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.
Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.
Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.
American Shared Hospital Services (AMS) has scheduled its Annual Meeting of Shareholders for June 21, 2022, at 8:30 a.m. PST. Due to COVID-19, the meeting will be virtual-only, prioritizing shareholder safety. Shareholders eligible to vote will be determined as of April 22, 2022. AMS specializes in providing advanced technology solutions for stereotactic radiosurgery and radiation therapy, including Gamma Knife equipment for treating brain tumors and other conditions. The press release cautions about various risks affecting the company’s growth and financial health.
American Shared Hospital Services (AMS) announces a joint venture to establish a cancer treatment facility in Puebla, Mexico, enhancing its international strategy. AMS will hold 85% ownership in the new company, responsible for upgrading a radiation therapy machine and providing advanced treatment options, including IMRT and radiosurgery. The facility aims to serve a region of over six million people, eliminating the need for long-distance travel for treatments. The facility is expected to be operational by early 2023, pending approvals.
American Shared Hospital Services (AMS) reported a strong Q4 2021, with revenue reaching $4.69 million, a 1.8% increase from Q4 2020.
Proton therapy revenue rose 20.1% to $1.68 million, while Gamma Knife revenue fell 6.3% to $3 million. Operating income was $723,000, compared to an $8.54 million loss in Q4 2020. For the full year, revenue decreased 1.2% to $17.63 million, but operating income improved significantly from a loss of $9.46 million in 2020 to a profit of $1.35 million. Cash at year-end was $8.26 million, indicating strong liquidity.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on March 24, 2022, at 4:00pm ET to discuss its Q4 and year-end 2021 financial results. The financial results press release will be available pre-market on the same day. AMS specializes in providing technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment. It is renowned for Gamma Knife radiosurgery systems and offers services in proton therapy and advanced imaging systems. For more details, visit ashs.com.
American Shared Hospital Services (AMS) reported preliminary Q4 2021 revenue of approximately $4.7 million, marking the highest quarterly revenue since the onset of the COVID-19 pandemic and stable compared to Q4 2020. For the full year, revenue totaled about $17.7 million, consistent with 2020 figures. The company noted improved operating income due to lower costs of revenue. Cash reserves increased to over $8 million, bolstered by a successful refinancing in Q2 2021. The final audited results will be released in late March 2022, accompanied by a quarterly conference call.
American Shared Hospital Services (AMS) announced a restructuring of its Board of Directors, reducing membership to five. Effective December 28, 2021, new directors Kathleen Miles and Vicki L. Wilson were appointed, while Sandra A. J. Lawrence resigned. Founding Chairman and CEO Ernest A. Bates, M.D., and David L. Larson, M.D. also resigned from the Board but will continue as consultants. Miles brings over 20 years of public finance experience, while Wilson has extensive financial management experience in the healthcare sector. This transition could signal a shift in governance aimed at enhancing operational efficiency and strategic direction.
American Shared Hospital Services (NYSE American: AMS) announced a strategic office relocation aimed at cost-saving. Effective December 1, 2021, the company will move to a smaller corporate office, resulting in estimated annual cash savings exceeding $115,000. The CEO, Ray Stachowiak, highlighted that the shift follows successful remote work adaptations during the COVID-19 pandemic, making the transition efficient. AMS is known for providing advanced stereotactic radiosurgery and radiation therapy technology.
American Shared Hospital Services (NYSE American: AMS) reported a 12.2% revenue decline to $4.1 million in Q3 2021, impacted by lower proton therapy volumes and COVID-19. Proton therapy revenue fell 23.4%, while Gamma Knife revenue decreased 5.9%. Despite this, the company achieved operating income of $186,000 compared to a loss last year. Net income was $33,000 vs. a loss of $209,000. AMS emphasizes its cost reductions leading to a 28.9% increase in gross margin and a strong cash position of $7.2 million, positioning for future growth.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call to discuss its third quarter 2021 financial results on November 10, 2021, at 3:00 PM EST / 12:00 PM PST. The press release detailing the financial results will be available premarket on the same day. The call will provide insights into the company's performance in providing advanced radiation therapy equipment and services, such as Gamma Knife radiosurgery and proton therapy.
American Shared Hospital Services (NYSE American: AMS) announced an expansion of its sales efforts to include federal healthcare facilities in the U.S., encompassing Veterans Affairs (VA) and Department of Defense (DoD) hospitals. This initiative follows a partnership with Growth Strategies in Motion (GSM) to enhance business development services. With $8.4 million in cash and a $7 million line of credit, AMS aims for sustained profitability. The company is known for its Gamma Knife radiosurgery equipment and advanced radiation therapy solutions.
